Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Selumetinib Plus Docetaxel Compared With Docetaxel Alone ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer
0
Authors
Pasi Jänne
19 more
Pasi Jänne
•
G Mariani
17 more
•
Johan Vansteenkiste
Published
May 9, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
JAMA
Topics
Medicine
Cancer Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Molecular Biology
Show all topics
DOI
10.1001/jama.2017.3438
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
JAMA
Topics
Medicine
Cancer Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Molecular Biology
Show all topics
DOI
10.1001/jama.2017.3438
Other Formats
PDF
